Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 35,867 | $155.29 | $5,569,786.43 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,435 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.6450 to $155.6450 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionOrdinary Shares | 51,000 | $77.07 | $3,930,570.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 6,539 | $157.27 | $1,028,388.53 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,302 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.9000 to $157.6500 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 3,415 | $156.38 | $534,037.70 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,841 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $155.8050 to $156.7750 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 10,131 | $155.24 | $1,572,736.44 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,256 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.7950 to $155.7550 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionOrdinary Shares | 28,085 | $69.72 | $1,958,086.20 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 16:35 UTC |
LEWIS DAVID BDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045477 · doc4.xml · derivative · entry 2 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,170 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board Service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 16:35 UTC |
LEWIS DAVID BDirector
|
GrantCareer Restricted Stock Units · Derivative | 519 | $158.00 | $82,002.00 |
DisclosureSEC source: 0001209191-20-045477 · doc4.xml · derivative · entry 1 LEWIS DAVID B · CIK 0001136554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,854 Underlying: Ordinary Shares · 519 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board Service. F3 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:40 UTC |
Fraser Mary ClareVice President & Chief HRO
|
GrantOrdinary Shares | 3,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045487 · doc4.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · Vice President & Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164 F1 · shares: These 3,164 ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2021; 791 on June 1, 2022; 791 on June 1, 2023; and 791 on June 3, 2024. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:39 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045485 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,248 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:37 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045481 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,570 Underlying: Ordinary Shares · 924 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:37 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,360 | $0.00 Strike: $158.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045481 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,360 Underlying: Ordinary Shares · 4,360 shares Expires 2030-08-04 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:36 UTC |
Shah Nirav RDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045479 · doc4.xml · derivative · entry 1 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,424 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:33 UTC |
KOSECOFF JACQUELINE BDirector
|
Tax withholdingOrdinary Shares | 532 | $158.00 | $84,056.00 |
DisclosureSEC source: 0001209191-20-045476 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784 F1 · shares: Ordinary shares withheld to satisfy taxes. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:33 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantOrdinary Shares | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045476 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316 Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:31 UTC |
HOLLAND CHRISTOPHER SDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045472 · doc4.xml · derivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:30 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,106 | $0.00 Strike: $158.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045470 · doc4.xml · derivative · entry 4 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,106 Underlying: Ordinary Shares · 3,106 shares Expires 2030-08-04 F3 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:28 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045467 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,100 Underlying: Ordinary Shares · 658 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:28 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 519 | $158.00 | $82,002.00 |
DisclosureSEC source: 0001209191-20-045467 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,442 Underlying: Ordinary Shares · 519 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $82,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:28 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,106 | $0.00 Strike: $158.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045467 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,106 Underlying: Ordinary Shares · 3,106 shares Expires 2030-08-04 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:05 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,168 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034115 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,168 Underlying: Ordinary Shares · 18,168 shares Expires 2030-06-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 4,542 on June 1, 2021; 4,542 on June 1, 2022; 4,542 on June 1, 2023 and 4,542 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:05 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Disposition to issuerOrdinary Shares | 771 | $165.65 | $127,716.15 |
DisclosureSEC source: 0001209191-20-034115 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,884 F2 · shares: 771 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 771 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 ordinary shares were awarded to Mr. Zangerle on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:05 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantOrdinary Shares | 3,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034115 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,655 F1 · shares: All 3,008 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,504 on June 1, 2022; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 44,472 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034046 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,472 Underlying: Ordinary Shares · 44,472 shares Expires 2030-06-01 F5 · derivative.exercise_date: This option becomes exercisable as follows: 11,118 on June 1, 2021; 11,118 on June 1, 2022; 11,118 on June 1, 2023 and 11,118 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Disposition to issuerOrdinary Shares | 1,454 | $165.65 | $240,855.10 |
DisclosureSEC source: 0001209191-20-034046 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,522 F2 · shares: 1,454 shares were withheld from the 4,700 restricted shares that vested on June 1, 2020. These 1,454 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,700 ordinary shares were awarded to Mr. Tokich on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034046 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,976 F1 · shares: All 2,452 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:32 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,536 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034040 · doc4.xml · derivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,536 Underlying: Ordinary Shares · 3,536 shares Expires 2030-06-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 884 on June 1, 2021; 884 on June 1, 2022; 884 on June 1, 2023 and 884 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:32 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Disposition to issuerOrdinary Shares | 132 | $165.65 | $21,865.80 |
DisclosureSEC source: 0001209191-20-034040 · doc4.xml · nonDerivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,929 F2 · shares: 132 shares were withheld from the 400 restricted shares that vested on June 1, 2020. These 132 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 400 ordinary shares were awarded to Mr. Tamaro on June 1, 2016. F3 · balance_after: 2,036 of these ordinary share are restricted. The restrictions on these ordinary shares lapse as follows: 412 on June 1, 2021; 484 on May 31, 2022; 556 on May 31, 2023 and 584 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:32 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034040 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,061 F1 · shares: All 584 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 99,464 | Not disclosed Strike: $182.22 | Not disclosed |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · derivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,464 Underlying: Ordinary Shares · 99,464 shares Expires 2030-06-01 F8 · price: This option becomes exercisable as follows: 24,866 on June 1, 2021; 24,866 on June 1, 2022; 24,866 on June 1, 2023 and 24,866 on June 3, 2024. F8 · derivative.exercise_date: This option becomes exercisable as follows: 24,866 on June 1, 2021; 24,866 on June 1, 2022; 24,866 on June 1, 2023 and 24,866 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Disposition to issuerOrdinary Shares | 2,150 | $165.65 | $356,147.50 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,302 F6 · shares: 2,150 shares were withheld from the 4,681 restricted shares that vested on June 1, 2020. These 2,150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,681 ordinary shares were awarded to Mr. Rosebrough on June 1, 2016 as part of an award of 18,724 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F7 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023 and 2,217 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Disposition to issuerOrdinary Shares | 1,165 | $165.65 | $192,982.25 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,452 F5 · shares: 1,165 shares were withheld from the 2,597 restricted shares that vested on June 1, 2020. These 1,165 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,597 ordinary shares were awarded to Mr. Rosebrough on May 31, 2019 as part of an award of 10,388 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Disposition to issuerOrdinary Shares | 1,413 | $165.65 | $234,063.45 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,617 F4 · shares: 1,413 shares were withheld from the 3,097 restricted shares that vested on June 1, 2020. These 1,413 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax law, as determined by the Issuer. These 3,097 ordinary shares were awarded to Mr. Rosebrough on May 31, 2018 as part of an award of 12,388 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Disposition to issuerOrdinary Shares | 1,839 | $165.65 | $304,630.35 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,030 F3 · shares: 1,839 shares were withheld from the 4,000 restricted shares that vested on June 1, 2020. These 1,839 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,000 ordinary shares were awarded to Mr. Rosebrough on May 30, 2017 as part of an award of 16,000 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantOrdinary Shares | 8,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,869 F1 · shares: All of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,217 on June 1, 2021; 2,217 on June 1, 2022; 2,217 on June 1, 2023 and 2,217 on June 3, 2024. F2 · balance_after: These 74,869 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:29 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,776 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034025 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,776 Underlying: Ordinary Shares · 26,776 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option becomes exercisable as follows: 6,694 on June 1, 2021, 6,694 on June 1, 2022, 6,694 on June 1, 2023 and 6,694 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:29 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Disposition to issuerOrdinary Shares | 747 | $165.65 | $123,740.55 |
DisclosureSEC source: 0001209191-20-034025 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F2 · shares: 747 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 747 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 shares were awarded to Mr. Carestio on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:29 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantOrdinary Shares | 4,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034025 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,061 F1 · shares: All 4,432 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:28 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,780 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034018 · doc4.xml · derivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Ordinary Shares · 4,780 shares Expires 2030-06-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 1,195 on June 1, 2021; 1,195 on June 1, 2022; 1,195 on June 1, 2023 and 1,195 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:28 UTC |
Burton Karen LVP, Controller & CAO
|
Disposition to issuerOrdinary Shares | 392 | $165.65 | $64,934.80 |
DisclosureSEC source: 0001209191-20-034018 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78 F2 · shares: 392 shares were withheld from the 1,220 restricted shares that vested on June 1, 2020. These 392 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,220 ordinary shares were awarded to Ms. Burton on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 6,144 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on June 1, 2021; 1,332 on May 31, 2022; 396 on June 1, 2022; 765 on May 31, 2022; 255 on May 31, 2023; 198 on June 1, 2023 and 198 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:28 UTC |
Burton Karen LVP, Controller & CAO
|
GrantOrdinary Shares | 792 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034018 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,286 F1 · shares: All 792 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 396 on June 1, 2022; 198 on June 1, 2023 and 198 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:26 UTC |
Majors Cary LSr VP N America Com Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,344 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034011 · doc4.xml · derivative · entry 4 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,344 Underlying: Ordinary Shares · 14,344 shares Expires 2030-06-01 F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,586 on June 1, 2021; 3,586 on June 1, 2022; 3,586 on June 1, 2023 3,586 and June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:26 UTC |
Majors Cary LSr VP N America Com Operations
|
Disposition to issuerOrdinary Shares | 747 | $165.65 | $123,740.55 |
DisclosureSEC source: 0001209191-20-034011 · doc4.xml · nonDerivative · entry 2 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,475 F2 · shares: 747 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 747 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 ordinary shares were awarded to Mr. Majors on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 13,620 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,500 on June 1, 2021; 2,520 on May 31, 2022; 2,224 on May 31, 2023 and 2,376 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:26 UTC |
Majors Cary LSr VP N America Com Operations
|
GrantOrdinary Shares | 2,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034011 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 F1 · shares: All 2,376 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on June 3, 2024. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:05 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GiftOrdinary Shares | 6,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033249 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 66,001 F1 · ownership.nature: These 66,001 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023 Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC |
Sohi MohsenDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,218 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC |
Sohi MohsenDirector
|
SaleOrdinary Shares | 550 | $164.68 | $90,574.00 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · nonDerivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,361 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $164.58 to $164.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC |
Sohi MohsenDirector
|
SaleOrdinary Share | 2,668 | $164.00 | $437,552.00 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,911 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $163.50 to $164.50 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC |
Sohi MohsenDirector
|
Exercise / conversionOrdinary Shares | 3,218 | $32.36 | $104,134.48 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:33 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Disposition to issuerOrdinary Shares | 4,000 | $162.70 | $650,800.00 |
DisclosureSEC source: 0001209191-20-033197 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,524 F1 · balance_after: 17,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.